Course Hero Logo

Pts 1 dif cognitive level knowledgeremembering ref p

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 447 - 449 out of 806 pages.

PTS:1DIF:Cognitive Level: Knowledge/RememberingREF:p. 702OBJ:Nursing Process: PlanningMSC: Client Needs: Physiologic Integrity20.Nafarelin (Synarel) is currently used as a treatment for mild to severe endometriosis. Thenurse should tell the woman taking this medication that the druga.stimulates the secretion of gonadotropin-releasing hormone (GnRH).b.may produce masculinizing effects.c.must be continued for at least a year.d.can cause her to experience some hot flashes and vaginal dryness.ANS: DNafarelin is a GnRH agonist, and its side effects are similar to those of menopause. Thehypoestrogenism effect results in hot flashes and vaginal dryness. Danazole, anothermediction to treat endometriosis causes masculinizing effects. Nararelin is used for 3 to 6months usually.PTS:1DIF:Cognitive Level: Comprehension/UnderstandingREF:p. 702OBJ:Integrated Process: Teaching-LearningMSC: Client Needs: Physiologic Integrity21.The nurse who is teaching a group of women about breast cancer should tell the women thata.risk factors identify almost all women who will develop breast cancer.b.African-American women have a higher rate of breast cancer.c.1 in 10 women in the United States will develop breast cancer in her lifetime.d.the exact cause of breast cancer is unknown.ANS: D
The exact cause of breast cancer in unknown. Risk factors help identify women who mayget breast cancer and for whom increased surveillance is recommended; however, breastcancer can occur without risk factors. Caucasian women have a higher incidence of breastcancer; however, African-American women have a higher rate of dying of breast cancerafter they are diagnosed. One in eight women in the United States will develop breast cancerin her lifetime.PTS:1DIF:Cognitive Level: Comprehension/UnderstandingREF:p. 694OBJ:Nursing Process: AssessmentMSC: Client Needs: Physiologic Integrity22.The nurse providing education regarding breast care should explain to the woman thatfibrocystic changes in breasts area.a disease of the milk ducts and glands in the breasts.b.a pre-malignant disorder characterized by lumps found in the breast tissue.c.lumpiness with pain and tenderness found in the breasts of healthy women.d.lumpiness accompanied by tenderness after menses.ANS: CFibrocystic changes are palpable thickenings in the breast usually associated with pain andtenderness. The pain and tenderness fluctuate with the menstrual cycle. Fibrocystic changesare palpable thickenings in the breast. Fibrocystic changes are not pre-malignant changes.This information is inaccurate. Fibrocystic changes are palpable thickenings in the breastusually associated with pain and tenderness. Most often tenderness occurs prior to menses.PTS:1DIF:Cognitive Level: Knowledge/RememberingREF:p. 694OBJ:Nursing Process: AssessmentMSC: Client Needs: Physiologic Integrity23.Which diagnostic test is used to confirm a suspected diagnosis of breast cancer?

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 806 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Fall
Professor
NoProfessor

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture